David M. Wurzer

Executive Vice President & Chief Investment Officer at Connecticut Innovations, Inc.

David M. Wurzer

David M. Wurzer

Executive Vice President & Chief Investment Officer at Connecticut Innovations, Inc.

Overview
Career Highlights

Connecticut Innovations, Inc.
CuraGen Corporation
Value Health, Inc.

RelSci Relationships

895

Number of Boards

21

Birthday

1959

Age

62

Number of Awards

1

Relationships
RelSci Relationships are individuals David M. Wurzer likely has professional access to. A relationship does not necessarily indicate a personal connection.

President at Frank M. Armstrong Consulting Ltd.

Relationship likelihood: Strong

Senior Managing Director at Aventri, Inc.

Relationship likelihood: Strong

Co-Founder at Thetis Pharmaceuticals LLC

Relationship likelihood: Strong

Co-Founder & Chief Executive Officer at Thetis Pharmaceuticals LLC

Relationship likelihood: Strong

Chief Financial Officer & Principal Accounting Officer at Arvinas, Inc.

Relationship likelihood: Strong

Heptagon Proof of Concept Fund

Relationship likelihood: Strong

Founder at OxStem Ltd.

Relationship likelihood: Strong

Managing Director, Venture Capital Investments at Connecticut Innovations, Inc.

Relationship likelihood: Strong

Managing Director, Venture Capital Investments at Connecticut Innovations, Inc.

Relationship likelihood: Strong

President at Polybiotics LLC

Relationship likelihood: Strong

Paths to David M. Wurzer
Potential Connections via
Relationship Science
You
David M. Wurzer
Executive Vice President & Chief Investment Officer at Connecticut Innovations, Inc.
Education
Bachelor of Business Administration in Accountancy
Class of 1980

The University of Notre Dame’s endowment provides nearly $100 million in financial aid annually to help students pay for college. Less than a generation ago, in 1990, the number was around $5 million. They’ve been able to keep pace with the rapidly growing financial needs of students, in part, by making smart investments in private equity.

Career History
Executive Vice President & Chief Investment Officer
2009 - Current

Connecticut Innovations invests in companies located in the US, primarily in Connecticut. The firm targets companies operating in the fields of bioscience, biomedical engineering, medical care, medical devices, pharmaceuticals, genomics, molecular science and biomedical engineering. The firm provides financing for seed and early stage ranging up to $500,000.

Executive Vice President, Treasurer & Chief Financial Officer
1997 - 2007

CuraGen Corp. develops protein, antibody and small molecule pharmaceutical products. The firm focuses on the development of CR011-vcMMAE, a Phase II clinical trial drug for the treatment of patients with metastatic melanoma and breast cancer. The company was founded in 1991 and is headquartered in Branford, CT.

Senior Vice President, Treasurer & Chief Financial Officer
1991 - 1997

Value Health, Inc. was a provider of specialty care benefit programs to insurance carriers, corporations, managed care organizations and federal, state and local governments. The company's businesses included pharmacy benefit management; mental health and substance abuse management; workers' compensation, disability and group health management and disease management. The company was founded by Robert E. Patricelli and Steve Shulman and was located in Avon, CT.

Boards & Committees
Director
Current

PolyBiotics LLC, a development stage company, intends to manufacture and distribute medical devices intended for administration of antibiotics for periodontal disease. The company was incorporated in 2009 and is based in Hamden, Connecticut.

Chairman of the Audit Committee
2010 - 2012

DUSA Pharmaceuticals, Inc. is an integrated dermatology pharmaceutical company, which develops and markets Levulan Photodynamic Therapy technology platform for the prevention and treatment of dermatological skin conditions. Its products include levulan kerastick, BLU-U and clindareach. The company was founded by D. Geoffrey Shulman on February 21, 1991 and is headquartered in Wilmington, MA.

Director
2000 - 2007

454 Life Sciences Corp. engages in the provision of medical testing services to determine the nucleotide sequence of whole genomes. The company was founded by Jonathan M. Rothberg in 2000 and is headquartered in Branford, CT.

Director
Current

TO PROVIDE QUALITY ENTERTAINMENT AT AFFORDABLE COSTS TO AS BROAD AN AUDIENCE AS POSSIBLE; TO PROVIDE EDUCATION AND OUTREACH OPPORTUNITIES FOR EMERGING AND COMMUNITY ARTISTS AND EDUCATORS; AND TO COLLABORATE WITH OTHER ARTS ORGANIZATIONS.

Political Donations
$100
2010

Governor at Connecticut Office of the Governor, Ned Lamont

$100
2006
$500
2000
Transactions
Details Hidden

Bio-Techne Corp., R&D Systems, Inc. purchase CyVek, Inc. from Connecticut Innovations, Inc.

Public Holdings
Restricted data only for RelSci Professional users.
Awards & Honors
CPA (Certified Public Accountant)
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by David M. Wurzer. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of David M. Wurzer's profile does not indicate a business or promotional relationship of any kind between RelSci and David M. Wurzer.